Oncoparse is striving to revolutionize the early detection and treatment monitoring of Pancreatic Cancer by developing a cutting-edge bioinformatics pipeline. This pipeline is set to dramatically increase the precision and efficacy of variant calling from non-invasive liquid biopsies.
Headquarter Australia |
Funding status Private |
Company type SME |
Chief Scientific Officer & Co-founder
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Chief Scientific Officer & Co-founder | hidden.item | hidden.item | hidden.item |